Related references
Note: Only part of the references are listed.A rapid and reliable method for the quantitation of hydroxychloroquine in serum using turbulent flow liquid chromatography-tandem mass spectrometry
Anna K. Fuezery et al.
CLINICA CHIMICA ACTA (2013)
A cross-sectional study of hydroxychloroquine concentrations and effects in people with systemic lupus erythematosus
S. J. Carmichael et al.
INTERNAL MEDICINE JOURNAL (2013)
Factors associated with blood hydroxychloroquine level in lupus patients: renal function could be important
J. Y. Lee et al.
LUPUS (2013)
Low Blood Concentration of Hydroxychloroquine in Patients With Refractory Cutaneous Lupus Erythematosus
Anne Cosnes
ARCHIVES OF DERMATOLOGY (2012)
Derivation and validation of the systemic lupus international collaborating clinics classification criteria for systemic lupus erythematosus
Michelle Petri et al.
ARTHRITIS AND RHEUMATISM (2012)
Cytochrome P450 variations in different ethnic populations
Joseph McGraw et al.
EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY (2012)
Method development and validation for rapid quantification of hydroxychloroquine in human blood using liquid chromatography-tandem mass Spectrometry
Ling-Zhi Wang et al.
JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS (2012)
Effect of CYP3A5, CYP3A4, and ABCB1 Genotypes as Determinants of Tacrolimus Dose and Clinical Outcomes After Heart Transplantation
B. Diaz-Molina et al.
TRANSPLANTATION PROCEEDINGS (2012)
Impact of Cytochrome P450 3A and ATP-Binding Cassette Subfamily B Member 1 Polymorphisms on Tacrolimus Dose-Adjusted Trough Concentrations Among Korean Renal Transplant Recipients
J. -H. Cho et al.
TRANSPLANTATION PROCEEDINGS (2012)
Discovery of a Novel Allelic Variant of CYP2C8, CYP2C8*11, in Asian Populations and Its Clinical Effect on the Rosiglitazone Disposition In Vivo
Chang-Woo Yeo et al.
DRUG METABOLISM AND DISPOSITION (2011)
Clinical and Pharmacogenetic Influences on Response to Hydroxychloroquine in Discoid Lupus Erythematosus: A Retrospective Cohort Study
Shyamal Wahie et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2011)
Pharmacogenetics: implications for therapy in rheumatic diseases
Lesley Davila et al.
NATURE REVIEWS RHEUMATOLOGY (2011)
Biological Resistance of Hydroxychloroquine for Plasmodium vivax Malaria in the Republic of Korea
Sei Won Lee et al.
AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE (2009)
Discovery of Novel Functional Variants and Extensive Evaluation of CYP2D6 Genetic Polymorphisms in Koreans
Su-Jun Lee et al.
DRUG METABOLISM AND DISPOSITION (2009)
New concepts in antimalarial use and mode of action in dermatology
Sunil Kalia et al.
DERMATOLOGIC THERAPY (2007)
CYP2C8 and antimalaria drug efficacy
J. P. Gill et al.
PHARMACOGENOMICS (2007)
Identifying drugs needing pharmacogenetic monitoring in a Korean hospital
Young Mi Kim et al.
AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY (2007)
Low blood concentration of hydroxychloroquine is a marker for and predictor of disease exacerbations in patients with systemic lupus erythematosus
Nathalie Costedoat-Chalumeau et al.
ARTHRITIS AND RHEUMATISM (2006)
Pharmacogenetics of disease-modifying anti-rheumatic drugs
E Tanaka et al.
BEST PRACTICE & RESEARCH IN CLINICAL RHEUMATOLOGY (2004)
Population pharmacokinetics of hydroxychloroquine in patients with rheumatoid arthritis
SJ Carmichael et al.
THERAPEUTIC DRUG MONITORING (2003)
Cytochrome P4502C8 and CYP3A4/5 are involved in chloroquine metabolism in human liver microsomes
KA Kim et al.
ARCHIVES OF PHARMACAL RESEARCH (2003)
In vitro metabolism of chloroquine:: Identification of CYP2C8, CYP3A4, and CYP2D6 as the main isoforms catalyzing N-desethylchloroquine formation
D Projean et al.
DRUG METABOLISM AND DISPOSITION (2003)
Genetic contribution to variable human CYP3A-mediated metabolism
JK Lamba et al.
ADVANCED DRUG DELIVERY REVIEWS (2002)
Interindividual variability and tissue-specificity in the expression of cytochrome P450 3A mRNA
I Koch et al.
DRUG METABOLISM AND DISPOSITION (2002)
Comparative metabolic capabilities of CYP3A4, CYP3A5, and CYP3A7
JA Williams et al.
DRUG METABOLISM AND DISPOSITION (2002)
Hydroxychloroquine concentration-response relationships in patients with rheumatoid arthritis
T Munster et al.
ARTHRITIS AND RHEUMATISM (2002)
Molecular genetics of CYP2D6:: Clinical relevance with focus on psychotropic drugs
L Bertilsson et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2002)
Frequencies of CYP2D6 mutant alleles in a normal Japanese population and metabolic activity of dextromethorphan O-demethylation in different CYP2D6 genotypes
T Kubota et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2000)
Share Paper
